Medication Treatment for Opioid Use Disorder in Expectant Mothers | MicrobiomeTrials← Back to trialsNCT03918850
Medication Treatment for Opioid Use Disorder in Expectant Mothers
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2020-07-21Est. Completion: 2025-01-31
Enrollment target: 140 participants Locations- Gateway Community Services, Jacksonville, Florida, United States
- Massachusetts General Hospital HOPE Clinic, Boston, Massachusetts, United States
- Boston Medical Center, Boston, Massachusetts, United States
- University of New Mexico Milagro Clinic, Albuquerque, New Mexico, United States
- University of Cincinnati Health Perinatal Addictions Program, Cincinnati, Ohio, United States
- CODA, Inc., Portland, Oregon, United States
- Pregnancy Recovery Center at Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- University of Utah SUPeRAD Clinic, Salt Lake City, Utah, United States
- Addiction Recovery Services (ARS), Swedish Medical Center, Seattle, Washington, United States
- Marshall Health MARC Program, Huntington, West Virginia, United States
Other microbiome trials you might be interested in
Pectus ExcavatumCryo AnalgesiaPhrenic Nerve-related Diaphragmatic Impairment
The goal of this observational ambispective study is to compare the effectiveness of two pain management strategies in p…
Bergamo, ItalyEst. completion Jul 16, 2026
Healthy VolunteerMajor Depressive DisorderDepression
Background:
Most medications that treat depression take weeks or months to work. Researchers want to develop fast-actin…
Bethesda, United StatesEst. completion Jan 1, 2027
Breast Cancer
Breast cancer remains the most frequently diagnosed cancer and a major cause of cancer-related mortality among women wor…
Cairo, EgyptEst. completion Aug 1, 2026